Rapid Development of Colorectal Neoplasia in Patients With Lynch Syndrome

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 4, 2011, Pages 340-343

  Edelstein, Daniel L ^a   Axilbund, Jennifer ^a   Baxter, Melanie ^a   Hylind, Linda M ^a   Romans, Katharine ^a   Griffin, Constance A ^a   Cruz Correa, Marcia ^b   Giardiello, Francis M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Colon Cancer; CRC; Mismatch Repair (MMR) Genes

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; FEMALE; GENE MUTATION; GENOTYPE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; YOUNG ADULT;

EID: 79952860470     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.10.033     Document Type: Article

References (16)

1. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932.
2. Gruber S.B. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology 2006, 130:577-587.
3. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997, 6:105-110.
4. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999, 81:214-218.
5. Lin K.M., Shashidharan M., Ternent C.A., et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 1998, 41:428-433.
6. Lin K.M., Shashidharan M., Thorson A.G., et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998, 2:67-71.
7. Winawer S.J., Fletcher R.H., Miller L., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594-642.
8. Vasen H.F. Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther 2007, 26(Suppl 2):113-126.
9. NCCN clinical practice guidelines in oncology colon cancer V.2.2010 Accessed Lynch Syndrome Surveillance. http://www.nccn.org/professionals/physician_gls/PDF/colon.pdf.
10. Mecklin J., Aarnio M., Laara E., et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 2007, 133:1093-1098.
11. Pendergrass C.J., Edelstein D.L., Hylind L.M., et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol 2008, 6:1011-1015.
12. Liljegren A., Lindblom A., Rotstein S., et al. Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 2003, 52:1140-1147.
13. Winawer S.J., Fletcher R.H., Miller L., et al. Colorectal cancer screening and surveillance: clinical guidelines, evidence, and rationale. Gastroenterology 1997, 112:594-642.
14. Ahlquist D.A. Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening. Gastroenterology 1995, 108:1590-1591.
15. Jass J.R., Stewart S.M., Lane M.R. Hereditary nonpolyposis colorectal cancer-morphologies, genes and mutations. Mutat Res 1994, 310:125-133.
16. Jarvinen H.J., AAronio M., Mustonen H., et al. Controlled 15 year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118:829-834.